[Liposomes of hypothalamic phospholipids: evaluation of their efficacy in subjects pretreated with sulpiride].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001007:Anxiety / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000627:therapeutic use*; D010900:Pituitary Diseases / Q000139:chemically induced / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood*; D013469:Sulpiride / Q000009:adverse effects; D013739:Testosterone / Q000097:blood
D010743:Phospholipids; D013739:Testosterone; D013469:Sulpiride; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
I liposomi di fosfolipidi ipotalamici: valutazione della loro efficacia in soggetti pretrattati con sulpiride.